Andy L. Nemeth, a director of Standex International Corporation (SXI), purchased 1,500 shares of the issuer's common stock on 08/29/2025 at a reported price of $205 per share. After the transaction he beneficially owned 6,000 shares. The Form 4 indicates the filing was executed on behalf of the reporting person and signed on 09/03/2025. The report contains no derivative transactions and lists the ownership form as direct. No additional explanation or context for the purchase is provided in the filing.
Standex International Corporation (SXI) filed a Form 144 reporting a proposed sale of 1,184 common shares through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $239,310.08 and 12,068,262 shares outstanding. The filer indicates an approximate sale date of 09/03/2025.
The shares were acquired on 08/23/2025 via restricted stock vesting from the issuer and the consideration is listed as compensation. The filer reports no securities sold in the past three months.
Ademir Sarcevic, Vice President/CFO/Treasurer and reporting person of Standex International Corp. (SXI), disclosed a sale of common stock on 08/26/2025. The filing reports the sale of 1,085 shares at a weighted-average sale price of $209.8642, with actual trade prices ranging from $209.175 to $210.41. After the transaction, the reporting person beneficially owns 11,164 shares, held directly. The Form 4 was signed and submitted on 08/28/2025.
Danielle Rangel, Vice President & Chief Accounting Officer of Standex International Corporation (SXI), reported several routine equity transactions on 08/22/2025–08/23/2025 tied to the company’s 2018 Omnibus Incentive Plan. 39 Restricted Stock Units vested and converted into 39 shares. Two small dispositions of 11 shares each occurred to cover taxes related to prior equity vesting. Separately, Rangel received an award of 207 Performance Share Units that cliff vest after three years (0–250% settlement based on performance), a grant of 207 Restricted Stock Units that vest one-third annually, and a contingent purchase resulting in 183 Phantom Stock Units that vest in three years and settle in common stock.
Alan J. Glass, CLO, VP & Secretary of Standex International Corp (SXI), filed a Form 4 reporting several transactions on 08/22/2025 and 08/23/2025 involving common stock, phantom stock units and restricted stock units. The filing shows multiple vestings and grants, including phantom stock vesting under the Management Stock Purchase Plan and awards under the 2018 Omnibus Incentive Plan. Certain shares were sold to pay taxes on vesting. Performance share units achieved 52% of target for one award, and new performance and restricted stock units were granted with multi-year vesting schedules. The Form is signed 08/26/2025.
Annmarie Bell, Vice President and Chief HR Officer of Standex International Corporation (SXI), reported multiple equity transactions on 08/22/2025 and 08/23/2025 related to vesting of incentive awards and tax-withholding sales. Phantom stock and restricted stock units vested, generating 613, 279 and 567 underlying shares from different awards, while portions of vested restricted stock/performance units were sold to pay taxes at an effective price of $210.48 per share. After these transactions the reporting person beneficially owned 8,606 shares directly. Performance share units were granted with a 0–250% payout formula and certain PSUs cliff vesting at three years; reported achievement for performance-based phantom units was 52%.
Standex International Corp director and President/CEO/Chairman David A. Dunbar reported multiple equity transactions on 08/22/2025 and 08/23/2025. Vesting events converted phantom stock units and restricted stock units into common shares, and some shares were sold to cover taxes. The filing shows net changes in direct beneficial ownership across several transactions with reported per-share price $210.48 for taxable sales. After the reported transactions Mr. Dunbar held both direct common shares (ending at 18,826.9759) and indirect interests (115,576 shares held by a trust), plus outstanding unvested performance and restricted awards.
Sarcevic Ademir, an officer (Vice President/CFO/Treasurer) of Standex International Corp. (SXI), reported multiple equity transactions on 08/22/2025 and 08/23/2025. The filing shows vesting of Phantom Stock Units and Restricted Stock Units under the companys 2018 Omnibus Incentive Plan, sales of shares to cover taxes on vesting, and a grant of 2,490 Performance Share Units that cliff vest on 08/23/2028. Several transactions were executed at a price of $210.48 per share, reflecting share sales tied to tax withholding. Following the reported transactions, the filing lists 12,249 beneficially owned shares of common stock (direct). The document describes formulaic achievement levels for performance awards (actual achievement 52% for certain phantom awards) and specifies vesting schedules for RSUs and PSUs.
Standex International Corp (SXI) reporting person Max Arets, VP and Chief Information Officer, filed a Form 4 disclosing equity activity on 08/22/2025 and 08/23/2025. 176 restricted stock units vested on 08/22/2025, resulting in 176 shares acquired at a deemed price of $210.48 and leaving 1,494.632 shares beneficially owned after the transaction. Also disclosed was a sale of 43 shares on 08/22/2025 to cover taxes. On 08/23/2025 the filer received grants and awards: 506 performance share units (cliff vesting at three years, 0–250% payout), 506 restricted stock units (vest one-third annually), and 684 phantom/contingent units combined (506 and 178) vesting in 2028.
Standex International Corporation (SXI) filing a Form 144 reports a proposed sale of 1,085 common shares by a person associated with the issuer. The shares are held at Fidelity Brokerage Services and the proposed approximate aggregate market value is $227,739.90 with an approximate sale date of 08/26/2025 on the NYSE. The shares were acquired by restricted stock vesting on 08/23/2025 and the payment is listed as compensation. The filer also disclosed a prior sale by the same person of 3,047 common shares on 08/06/2025 that generated gross proceeds of $584,446.61. The filer attests there is no undisclosed material adverse information and includes the standard signature and legal warnings.